Article

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

2021-05-14

Abstract excerpt

<h4>Background: </h4> Tumor mutation burden is an emerging biomarker for immunotherapy. Although several clinical trials for immunotherapy in lymphoma have been carried out, the mutation burden of various lymphomas is not well known yet. Thus, the objective of this study was to compare tumor mutation burden of various non-Hodgkin lymphomas using panel based massively parallel sequencing. <h4>Methods: </h4>: We con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 04b78057-1934-5d31-9aeb-2d7a9e9efab6
DOI: 10.21203/rs.3.rs-428182/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencingDOI 10.21203/rs.3.rs-428182/v1Read

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing.Semantic proximity Read

Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.Semantic proximity Read

Next-generation sequencing discoveries in lymphoma.Semantic proximity Read

The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencingSemantic proximity Read

Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.Semantic proximity Read

Indications of next-generation sequencing in non-Hodgkin's lymphoma.Semantic proximity Read

Mutational Profiling of Korean Lymphomas and Diffuse Large B-Cell Lymphoma Subtype Classification Using Targeted Panel Sequencing.Semantic proximity Read

Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.Semantic proximity Read

Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.Semantic proximity Read

Tumor mutational burden measurement using comprehensive genomic profiling assay.Semantic proximity Read

Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristicsSemantic proximity Read

Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.Semantic proximity Read